Triple-arm trial of pH (Tri-pH) effect on live birth after ICSI in Egyptian IVF facilities: protocol of a randomised controlled trial

Mohamed Fawzy, Mai Emad, Jack Wilkinson, Ragaa Mansour, Ali Mahran, Ahmed Fetih, Mohamed Abdelrahman, Hazem AbdelGhafar, Mohamed Fawzy, Mai Emad, Jack Wilkinson, Ragaa Mansour, Ali Mahran, Ahmed Fetih, Mohamed Abdelrahman, Hazem AbdelGhafar

Abstract

Introduction: One potential stressor that can affect preimplantation and postimplantation embryonic growth after in vitro fertilisation (IVF) is the pH of the human embryo culture medium, but no evidence exists to indicate which pH level is optimal for IVF. Based on anecdotal evidence or mouse models, culture media manufacturers recommend a pH range of 7.2 to 7.4, and IVF laboratories routinely use a pH range of 7.25 to 7.3. Given the lack of randomised trials evaluating the effect of pH on live birth rate after IVF, this trial examines the effect of three different pH levels on the live birth rate.

Methods and analysis: This multicentre randomised trial will involve centres specialised in IVF in Egypt. Eligible couples for intracytoplasmic sperm injection (ICSI) will be randomised for embryo culture at pH 7.2, 7.3 or 7.4. The study is designed to detect 10 percentage points difference in live birth rate between the best and worst performing media with 93% power at a 1% significance level. The primary outcome is the rate of live birth (delivery of one or more viable infants beyond the 20th week of gestation) after ICSI. Secondary clinical outcomes include biochemical pregnancy, clinical pregnancy, ongoing pregnancy, miscarriage, preterm births, birth weight, stillbirth, congenital malformation and cumulative live birth (within 1 year from randomisation). Embryo development outcomes include fertilisation, blastocyst formation and quality, and embryo cryopreservation and utilisation.

Ethics and dissemination: The study was reviewed and approved by the Ethics Review Boards of the participating centres. Eligible women will sign a written informed consent before enrolment. This study has an independent data monitoring and safety committee comprised international experts in trial design and in vitro culture. No plan exists to disseminate results to participants or health communities, except for the independent monitoring and safety committee of the trial.

Trial registration number: NCT02896777.

Keywords: blastocyst formation; culture media; embryo culture; pH level.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Trial plan for enrolment. pH trial plan for enrolment and outcomes – 7.2, 7.3 and 7.4 pH levels.

References

    1. Smith ADAC, Tilling K, Nelson SM, et al. . Live-Birth rate associated with repeat in vitro fertilization treatment cycles. JAMA 2015;314:2654–62. 10.1001/jama.2015.17296
    1. Berntsen S, Söderström-Anttila V, Wennerholm U-B, et al. . The health of children conceived by ART: 'the chicken or the egg?'. Hum Reprod Update 2019;25:137–58. 10.1093/humupd/dmz001
    1. Pool TB, Schoolfield J, Han D. Human embryo culture media comparisons. Methods Mol Biol 2012;912:367–86.
    1. Swain JE. Is there an optimal pH for culture media used in clinical IVF? Hum Reprod Update 2012;18:333–9. 10.1093/humupd/dmr053
    1. Tarahomi M, de Melker AA, van Wely M, et al. . pH stability of human preimplantation embryo culture media: effects of culture and batches. Reprod Biomed Online 2018;37:409–14. 10.1016/j.rbmo.2018.08.011
    1. Shalgi R, Kraicer PF, Soferman N. Gases and electrolytes of human follicular fluid. Reproduction 1972;28:335–40. 10.1530/jrf.0.0280335
    1. Phillips KP, et al. Intracellular pH regulation in human preimplantation embryos. Hum Reprod 2000;15:896–904. 10.1093/humrep/15.4.896
    1. FitzHarris G, Siyanov V, Baltz JM. Granulosa cells regulate oocyte intracellular pH against acidosis in preantral follicles by multiple mechanisms. Development 2007;134:4283–95. 10.1242/dev.005272
    1. Dale B, Menezo Y, Cohen J, et al. . Intracellular pH regulation in the human oocyte. Human Reproduction 1998;13:964–70. 10.1093/humrep/13.4.964
    1. Lane M, Baltz JM, Bavister BD. Na+/H+Antiporter activity in hamster embryos is activated during fertilization. Dev Biol 1999;208:244–52. 10.1006/dbio.1999.9198
    1. Swain JE, Pool TB. New pH-buffering system for media utilized during gamete and embryo manipulations for assisted reproduction. Reprod Biomed Online 2009;18:799–810. 10.1016/S1472-6483(10)60029-6
    1. Hentemann M, Mousavi K, Bertheussen K. Differential pH in embryo culture. Fertil Steril 2011;95:1291–4. 10.1016/j.fertnstert.2010.10.018
    1. Carney EW, Bavister BD. Regulation of hamster embryo development in vitro by carbon Dioxide1. Biol Reprod 1987;36:1155–63. 10.1095/biolreprod36.5.1155
    1. Edwards LJ, Williams DA, Gardner DK. Intracellular pH of the mouse preimplantation embryo: amino acids act as buffers of intracellular pH. Human Reproduction 1998;13:3441–8. 10.1093/humrep/13.12.3441
    1. Edwards LJ, Williams DA, Gardner DK. Intracellular pH of the preimplantation mouse embryo: effects of extracellular pH and weak acids. Mol Reprod Dev 1998;50:434–42. 10.1002/(SICI)1098-2795(199808)50:4<434::AID-MRD7>;2-J
    1. World Health Organization Who laboratory manual for the examination and processing of human semen. Geneva: World Health Organization, 2010.
    1. Palermo G, et al. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. The Lancet 1992;340:17–18. 10.1016/0140-6736(92)92425-F
    1. Mortimer D, Cohen J, Mortimer ST, et al. . Cairo consensus on the IVF laboratory environment and air quality: report of an expert meeting. Reprod Biomed Online 2018;36:658–74. 10.1016/j.rbmo.2018.02.005
    1. Medicine ASIR, Embryology ESIG Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod Biomed Online 2011;22:632–46. 10.1016/j.rbmo.2011.02.001
    1. Duffy JMN, Bhattacharya S, Curtis C, et al. . A protocol developing, disseminating and implementing a core outcome set for infertility. Hum Reprod Open 2018;2018:hoy007 10.1093/hropen/hoy007
    1. Williams J. The Declaration of Helsinki and public health. Bull World Health Organ 2008;86:650–1. 10.2471/BLT.08.050955
    1. Schulz KF, Altman DG, Moher D, et al. . Consort 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332 10.1136/bmj.c332

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi